chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Bradycardia, Dizziness, Heart rate decreased, Palpitations
Clinical narrative: Heart palpitations and dizziness. Bradycardia. Resting heart rate dropped as low as 40 beats per minute.
Age: 15.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Palpitations
Clinical narrative: Chest pain and palpitations
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Oligomenorrhoea
Clinical narrative: Increased length of menstrual cycle. Average cycle 34 days per 1.5 years of data. Menstruation sure shortly after vaccine administration. Cycle length that time was 58 days, longer than any other in last years.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: Intense intermittent itching in specific spots. It is usually on my arms, abdomen, lateral breast tissue, or base of head/upper cervical. Rarely in two places at once. I?ve tried taking allergy medication which has not helped. The frequency has become less often but still happens intermittently.
Age: 63.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Asthenopia, Blindness, Blindness unilateral, Conjunctival haemorrhage, Dizziness
Clinical narrative: 4/24 ? first vaccine at 2:00 pm  5/15 ? second dose at 2:00   After receiving second shot, during waited 15 minutes and felt dizzy during the wait period but came home because son drove me to the appointment.  That night, I felt very dizzy and had cold symptoms so took Tylenol every six hours ? from May 15 ? 21st.   I could not volunteer/work because of poor health conditions after getting vaccine and took a leave of absence.   I felt okay afterwards until June 1st. On June 1st, my left eye was swollen and my eye felt fatigued. I rested my eyes but started losing vision little by little in my left eye. On June 5th, my left eye hurt severely. I made appointment with an optometrist on June 6th and saw the optometrist on 7th at noon.  During the check up, the doctor reported that the blood vessels had ruptured behind my cornea and the inside of my eye was filled with blood. He was not equipped to handle this situation so he gave referral to an eye specialist (for special eye part) and went to an appointment on June 10th.  When I went to the specialist, he reported that the inside of eye was filled with blood, which was causing the blindness. He performed laser treatment and advised that I return for a check up after 5 weeks and advised to stay at home, no driving, avoid bright lights, etc. I followed the doctor's orders and stayed home for 5 weeks.   I returned to the eye specialist for my 5-week check up on July 15th and the doctor reported that the condition has not gotten better. I still could not see from left eye. The doctor performed a second laser treatment on the 15th and advised to return for check-up after 6 weeks because of the severity of the condition. The doctor said that I needed extra time to recover. If conditions do not improve, he said that I will need to get surgery and additional treatment for my eye sight to return.  I am currently 1 week into the second laser treatment and my condition has not improved.
Age: 63.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Eye haemorrhage, Eye laser surgery, Eye pain, Eye swelling, Impaired driving ability
Clinical narrative: 4/24 ? first vaccine at 2:00 pm  5/15 ? second dose at 2:00   After receiving second shot, during waited 15 minutes and felt dizzy during the wait period but came home because son drove me to the appointment.  That night, I felt very dizzy and had cold symptoms so took Tylenol every six hours ? from May 15 ? 21st.   I could not volunteer/work because of poor health conditions after getting vaccine and took a leave of absence.   I felt okay afterwards until June 1st. On June 1st, my left eye was swollen and my eye felt fatigued. I rested my eyes but started losing vision little by little in my left eye. On June 5th, my left eye hurt severely. I made appointment with an optometrist on June 6th and saw the optometrist on 7th at noon.  During the check up, the doctor reported that the blood vessels had ruptured behind my cornea and the inside of my eye was filled with blood. He was not equipped to handle this situation so he gave referral to an eye specialist (for special eye part) and went to an appointment on June 10th.  When I went to the specialist, he reported that the inside of eye was filled with blood, which was causing the blindness. He performed laser treatment and advised that I return for a check up after 5 weeks and advised to stay at home, no driving, avoid bright lights, etc. I followed the doctor's orders and stayed home for 5 weeks.   I returned to the eye specialist for my 5-week check up on July 15th and the doctor reported that the condition has not gotten better. I still could not see from left eye. The doctor performed a second laser treatment on the 15th and advised to return for check-up after 6 weeks because of the severity of the condition. The doctor said that I needed extra time to recover. If conditions do not improve, he said that I will need to get surgery and additional treatment for my eye sight to return.  I am currently 1 week into the second laser treatment and my condition has not improved.
Age: 63.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Impaired work ability, Nasopharyngitis, Ocular hyperaemia, Ophthalmological examination abnormal
Clinical narrative: 4/24 ? first vaccine at 2:00 pm  5/15 ? second dose at 2:00   After receiving second shot, during waited 15 minutes and felt dizzy during the wait period but came home because son drove me to the appointment.  That night, I felt very dizzy and had cold symptoms so took Tylenol every six hours ? from May 15 ? 21st.   I could not volunteer/work because of poor health conditions after getting vaccine and took a leave of absence.   I felt okay afterwards until June 1st. On June 1st, my left eye was swollen and my eye felt fatigued. I rested my eyes but started losing vision little by little in my left eye. On June 5th, my left eye hurt severely. I made appointment with an optometrist on June 6th and saw the optometrist on 7th at noon.  During the check up, the doctor reported that the blood vessels had ruptured behind my cornea and the inside of my eye was filled with blood. He was not equipped to handle this situation so he gave referral to an eye specialist (for special eye part) and went to an appointment on June 10th.  When I went to the specialist, he reported that the inside of eye was filled with blood, which was causing the blindness. He performed laser treatment and advised that I return for a check up after 5 weeks and advised to stay at home, no driving, avoid bright lights, etc. I followed the doctor's orders and stayed home for 5 weeks.   I returned to the eye specialist for my 5-week check up on July 15th and the doctor reported that the condition has not gotten better. I still could not see from left eye. The doctor performed a second laser treatment on the 15th and advised to return for check-up after 6 weeks because of the severity of the condition. The doctor said that I needed extra time to recover. If conditions do not improve, he said that I will need to get surgery and additional treatment for my eye sight to return.  I am currently 1 week into the second laser treatment and my condition has not improved.
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19 pneumonia, SARS-CoV-2 test positive
Clinical narrative: hosp for covid pneumonia
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Confusional state, Loss of consciousness, Malaise
Clinical narrative: Patient received the dose at 5:15pm. I was alerted by father at 5:25 that she was not feeling well. I went to check on her and she had lost consciousness in her father's arms. I told the technician to call 911 at retrieved and epipen. I opened the epipen and checked the patient for response. She woke up and appeared very weak and confused. She responded that she could breathe. The epipen was not administered. EMS arrived and checked for vitals. Vitals were within normal range. The father decline transportation for further care. She remained sitting until 5:50 pm and she left on her own power with her family.
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Dizziness, Palpitations
Clinical narrative: Racing heart palpitations and chest pain with extreme dizziness
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Crying, Dizziness, Hyperventilation
Clinical narrative: Per triage nurse, " Pt feeling dizzy and began to cry stated she did not want to pass out, was hyperventilating, given fruit snacks. Pt was helped to the ground, legs were elevated and vitals were taken. Vitals all WNL, oxygen via nasal canula at 2L was applied. Pt was able to answer basic questions, would take a while to answer. Dr. stated that patients vitals were fine and that nursing should keep patient in a calm environment and sit her up. Patient was given juice and fruit snacks, nurse and medic  were present on site. Patient unable to tolerate sitting up, medic and nurse transferred patient over to gurney and was taken to ambulance past border."
Age: 13.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoaesthesia
Clinical narrative: Client was in observation room with Grandmother and reported to EMTs he was feeling numbness to left arm. EMT alerted RN. RN arrived at 1631, client alert and oriented x4, sitting upright in chair. Vitals at 1635: blood pressure 146/88, pulse 80, oxygen 98%. Medical history of ADHD, no current medication and no known allergies. Per client it has been 2 years since taking ADHD medication. Client reports no history of arm injuries to left forearm in the past. RN assessed for sensory and motor of arm. Client able to move arm and reported feeling stimuli. Per client only numbness to left forearm. Vaccine administered to left Deltoid at 1609. RN gave client Capri-Sun and client drank slowly. EMT's stayed with client remaining of observation time. Vitals at 1643: blood pressure 138/76, pulse 96, oxygen 97%. Per client arm numbness improving. At 1651 client and Grandmother approached EMT table and stated he wanted to leave. EMT educated client and Grandmother member present of ER precautions and following up with medical provider. Client left facility at 1652 with steady gait.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain, Injection site pruritus, Sleep disorder
Clinical narrative: Several weeks ago I started having an extreme and painful itch in my upper left arm.  I tried to ignore it, but it is so extreme it keeps me from sleeping.  Finally, as the severity and area of my arm affected increased, I went to the Emergency Room.  The ER doctor thought that it must be symptoms of a bug bite.  That had not occurred to me before, because I had not noticed being stung or bitten, and there have been no visible bite or sting marks on my arm.  However, I have always had a more severe reaction than the average person to bees, mosquitos and sting rays.  The doctor prescribed prescription steroids and OTC Benadryl.  I have been taking these two medicines for the past 5 days but my symptoms have NOT alleviated.  Even considering my normal bad reactions to bites and stings, I should be seeing improvement if that diagnosis were correct.  Today after I was reviewing the current status of the COVID pandemic, I got my "v-safe check-in" on the phone, and it suddenly occurred to me that I am having these symptoms at the site of my COVID vaccination shots.  So I'm wondering...if it could be relevant...
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Condition aggravated, Dyspnoea, Electromyogram abnormal, Gait disturbance, Guillain-Barre syndrome
Clinical narrative: Guillain Barre Syndrome
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Muscular weakness, Nerve conduction studies, Respiratory failure
Clinical narrative: Guillain Barre Syndrome
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Guillain-Barre syndrome, Laboratory test, Lumbar puncture, Magnetic resonance imaging head, Magnetic resonance imaging spinal
Clinical narrative: Guillain Barre Syndrome
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Ophthalmoplegia, Quadriparesis, Respiratory failure
Clinical narrative: Guillain Barre Syndrome
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Interchange of vaccine products
Clinical narrative: Patient received incorrect second COVID-19 vaccine dose. Patient received Pfizer instead of Moderna.
Age: 32.0
Sex: M
Vaccine: COVID19
Symptoms: Head injury, Magnetic resonance imaging normal, Syncope
Clinical narrative: Patient reported on 7/22/21 the following incident: On 7/17/21, the day after receiving the second Pfizer vaccine, the patient fainted and hit his head to the floor. He was taken to the ER. Doctor performed MRI to make sure if there was any internal injury, which did not show internal injuries at the time. Patient was advised to see his family doctor and then discharged after a few hours. Patient saw his family doctor on 7-22-21, which referred him to cardiologists and neurologist. Patient is currently waiting for appointments from the specialists. Patient seemed to be feeling well at the time of talking to the pharmacist and did not have any health complain at the time.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Decreased appetite, Dysgeusia, Fatigue, Immediate post-injection reaction, Nausea
Clinical narrative: Immediate metallic taste severe fatigue, loss of appetite & nausea.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Abortion missed, Maternal exposure before pregnancy, Pregnancy, Pregnancy test urine positive, Ultrasound scan abnormal
Clinical narrative: Pregnancy on 4/1/21. Pregnancy confirmation ultrasound on 5/13/21 showed missed abortion. D&C performed 5/14/21.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Uterine dilation and curettage
Clinical narrative: Pregnancy on 4/1/21. Pregnancy confirmation ultrasound on 5/13/21 showed missed abortion. D&C performed 5/14/21.
Age: 27.0
Sex: M
Vaccine: COVID19
Symptoms: Carditis, Chest pain, Dyspnoea, Electrocardiogram, Headache
Clinical narrative: Heart inflammation, fever, headache, arm ache, chest pain, shortness of breath, pulsing pain throughout body, extreme pain at injection site, injection site was very hot to the touch, redness at injection site, swelling at injection site
Age: 27.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Injection site warmth, Pain
Clinical narrative: Heart inflammation, fever, headache, arm ache, chest pain, shortness of breath, pulsing pain throughout body, extreme pain at injection site, injection site was very hot to the touch, redness at injection site, swelling at injection site
Age: 27.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia
Clinical narrative: Heart inflammation, fever, headache, arm ache, chest pain, shortness of breath, pulsing pain throughout body, extreme pain at injection site, injection site was very hot to the touch, redness at injection site, swelling at injection site
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Anosmia, Chills, Decreased appetite, Diarrhoea, Eye pain
Clinical narrative: Almost 24 hours after receiving my shot on 7/20/2021 I felt extreme fatigue, malaise, moderate to severe headache and eye pain,  chills all over body with sensitivity to skin all over body, diarrhea, loss of appetite, loss of smell. All of these symptoms have continued 48 hours later with no relief.
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Hyperaesthesia, Malaise
Clinical narrative: Almost 24 hours after receiving my shot on 7/20/2021 I felt extreme fatigue, malaise, moderate to severe headache and eye pain,  chills all over body with sensitivity to skin all over body, diarrhea, loss of appetite, loss of smell. All of these symptoms have continued 48 hours later with no relief.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Electric shock sensation, Paraesthesia, Sleep disorder
Clinical narrative: The night of my second Pfizer shot I developed very bad paresthesia.  Very intense "electrical shocks" in my shins.  Strong enough to wake me from sleep.  These seemed to pass away for a few weeks but then returned about 3 weeks later and have continued as of this date (7/22/2021).  I feel shocks and pin pricks globally all over my body several times a minute.  Sometimes more than once within ten seconds.  This has been my daily experience since early June 2021.  The intensity of the sensation is less, but the frequency is extreme.
Age: 4.0
Sex: M
Vaccine: DTAPIPV, MMRV
Symptoms: Skin reaction, Tenderness
Clinical narrative: local skin reaction measure up to 3cm in diameter with slight tenderness
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Dizziness, Feeling abnormal, Heart rate increased, Oropharyngeal pain
Clinical narrative: After my 1st dose?..I experienced severe arm pain at shot for several days. Headache within 4 hours from getting the shot which continued for up to two days after. Sore throat. Chest tightness and heart beating fast a few days after shot. Today is almost a week after getting first dose and I still feel off. Lightheaded now and them. Throat still killing me. Chest still feels like it has  pressure . Not sure what is going on but after this one shot and I had reaction like this?.not sure I?ll get the 2nd dose.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: After my 1st dose?..I experienced severe arm pain at shot for several days. Headache within 4 hours from getting the shot which continued for up to two days after. Sore throat. Chest tightness and heart beating fast a few days after shot. Today is almost a week after getting first dose and I still feel off. Lightheaded now and them. Throat still killing me. Chest still feels like it has  pressure . Not sure what is going on but after this one shot and I had reaction like this?.not sure I?ll get the 2nd dose.
Age: 24.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Feeling hot, Hyperhidrosis
Clinical narrative: Patient was vaccinate at 1410, in which at 1413 he stated he was feeling hot and light headed. Patient began sweating profusely. Cold compresses were applied to his neck and chest area. His blood pressure  was noted at 104/52 at 1413, and 144/98 at 1420. 911 was called at 1413. EMT arrived at 1430 and released client at 1435 with him agreeing to feeling better.  Client left our site at 1445 stating he was feeling OK.  Note: Client temporally lives in nearby apartment complex and walked back on his own.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Disorientation, Feeling hot, Palpitations
Clinical narrative: pt recieved vaccination. after recieving vaccination pt approached counter stating having palpiations and felt warm. we offered to call emergency medical services but patient declined offer. pt stated she will sit down for a little. after 10 minutes pt stated palpiations went away but feeling a little disoriented. she was instructed to wait in store for 30 minutes and recommended that she call for someone to drive her home. she called friend who came to get her and daughter to get her car. she walked out of store by herself to friend/family stating feeling better. before leaving she was instructed that if adverse reactions reoccurs or others arrise to call 911 to seek immediate medical attention.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Arthralgia, Blood pressure normal, Condition aggravated, Dry mouth
Clinical narrative: Anxiety, panic attacks, heart palpation, strange taste in mouth, tingling throughout body right after shot, strange sensation with tongue, shakiness, pale cold hands, dry mouth.  Blood pressure was fine, elevated heartbeat.   Discharged but had rolling panic attacks throughout the day. Muscle and joint pain, headache
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Heart rate increased, Myalgia, Palpitations, Panic attack
Clinical narrative: Anxiety, panic attacks, heart palpation, strange taste in mouth, tingling throughout body right after shot, strange sensation with tongue, shakiness, pale cold hands, dry mouth.  Blood pressure was fine, elevated heartbeat.   Discharged but had rolling panic attacks throughout the day. Muscle and joint pain, headache
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia, Peripheral coldness, Sensory disturbance, Skin discolouration, Taste disorder
Clinical narrative: Anxiety, panic attacks, heart palpation, strange taste in mouth, tingling throughout body right after shot, strange sensation with tongue, shakiness, pale cold hands, dry mouth.  Blood pressure was fine, elevated heartbeat.   Discharged but had rolling panic attacks throughout the day. Muscle and joint pain, headache
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Tremor
Clinical narrative: Anxiety, panic attacks, heart palpation, strange taste in mouth, tingling throughout body right after shot, strange sensation with tongue, shakiness, pale cold hands, dry mouth.  Blood pressure was fine, elevated heartbeat.   Discharged but had rolling panic attacks throughout the day. Muscle and joint pain, headache
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Headache, Nasal congestion, Oropharyngeal pain
Clinical narrative: Patient developed symptoms of headache, nasal congestion, sore throat, and mild cough on 07/20.  She tested positive for COVID on 7/22/2021.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Patient developed symptoms of headache, nasal congestion, sore throat, and mild cough on 07/20.  She tested positive for COVID on 7/22/2021.
Age: 73.0
Sex: F
Vaccine: VARZOS
Symptoms: Contusion, Injection site erythema, Swelling
Clinical narrative: Injection site  redness,swelling, and bruising
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Loss of consciousness, Syncope
Clinical narrative: PATIENT FAINTED, MOMENTARILY BLACKED OUT
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Dyspnoea, Neck pain, Pain, Skin warm
Clinical narrative: woke up with pain that shot up to the neck. the area was swollen and hot. which prompt patient to go to ER. The physician subsequently diagnosed patient with superficial arm blood clot. patient has a follow up visit to investigate if a presence of blood clot which is causing  sob is related to the immunization
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Sleep disorder, Swelling, Thrombophlebitis superficial, Ultrasound scan
Clinical narrative: woke up with pain that shot up to the neck. the area was swollen and hot. which prompt patient to go to ER. The physician subsequently diagnosed patient with superficial arm blood clot. patient has a follow up visit to investigate if a presence of blood clot which is causing  sob is related to the immunization
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: Severe muscle aches all over body for about 36 hours
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: Balance disorder, Hyperhidrosis, Vision blurred
Clinical narrative: pt received vaccine at 4:55 pm, at 5:01 PM he returned to office door and states he felt his right eye getting blurry and he started to stagger and lose balance, and started to sweat,   he was helped to the exam table , he laid on exam table  he continued to talk to provider while laying down,  --  he laid down about 15 minutes,  his first  bp upon laying down  was 90/60,  bp 15 minutes later 110/60.  He drank some water, states he felt better now, gait steady,
Age: 21.0
Sex: M
Vaccine: UNK
Symptoms: Facial paralysis, Ophthalmoplegia, Pain, Speech disorder
Clinical narrative: Eye and facial paralysis, trouble speaking, pain.
Age: 14.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Headache
Clinical narrative: Pt. had her 2nd  Pfizer shot on July 14, 2021.  Two days later, on July 16, 2021 approximately 4:58pm, she developed chest pain and light  headache. She took 2 Tylenol pills and the 10- 15 mins the pain went away.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea
Clinical narrative: Extreme shortness of breath. Initially 1 day a week for 15 min. Then every other day, then every day, then twice a day. Length of attacks now ranges 15min-all day.
Age: 18.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Breast induration, Costochondritis, Injection site pain, Injection site swelling
Clinical narrative: Injection site pain, swelling.  On Saturday noticed swelling in underarm and hardening of breast tissues.  Went to PCP on Monday 7/19 and was diagnosed with costochondritis and myalgia of the neck, chest and back.  Patient given meloxicam and sent home.
Age: 18.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Musculoskeletal chest pain, Myalgia, Neck pain
Clinical narrative: Injection site pain, swelling.  On Saturday noticed swelling in underarm and hardening of breast tissues.  Went to PCP on Monday 7/19 and was diagnosed with costochondritis and myalgia of the neck, chest and back.  Patient given meloxicam and sent home.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Dyspnoea, Hypoaesthesia oral, Pruritus
Clinical narrative: Extreme chest tightness, SOB, numbness of mouth and tongue - facial itching Placed on combination of Ativan, Benedryl + Zyrtec for 3 days to calm symptoms Out of work x3D
Age: 82.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, C-reactive protein increased, Fatigue, Myalgia
Clinical narrative: About 20 days after the second Moderna Covid-19 vaccine Pt started with acute arthralgias, myalgias, and extreme fatigue. Treated with Hydroxychloroquine 200 mg, B complex and Traumeric.
Age: 73.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Blood homocysteine, C-reactive protein increased, Diarrhoea, Fatigue
Clinical narrative: About 3 weeks after patient had the second dose of Moderna Covid-19 vaccine He started with extreme fatigue, diarrhea, high blood pressure, join pain, muscle pain, join swelling, restricted motion or stiffness, headache syndrome.
Age: 73.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Headache, Hypertension, Interleukin level, Joint range of motion decreased, Joint swelling
Clinical narrative: About 3 weeks after patient had the second dose of Moderna Covid-19 vaccine He started with extreme fatigue, diarrhea, high blood pressure, join pain, muscle pain, join swelling, restricted motion or stiffness, headache syndrome.
Age: 73.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Musculoskeletal stiffness, Myalgia
Clinical narrative: About 3 weeks after patient had the second dose of Moderna Covid-19 vaccine He started with extreme fatigue, diarrhea, high blood pressure, join pain, muscle pain, join swelling, restricted motion or stiffness, headache syndrome.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Blood iron, C-reactive protein, Fatigue, Feeling abnormal
Clinical narrative: Weakness, body pain, hold and cold temperature to extremities - started approx 2 hours after vaccine administration,  Acute onset since receiving vaccine - low blood count, feeling cold daily, fatigue, feeling terrible, feeling weak, feeling like she is going to pass out.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Feeling cold, Full blood count decreased, Iron binding capacity total, Metabolic function test, Pain
Clinical narrative: Weakness, body pain, hold and cold temperature to extremities - started approx 2 hours after vaccine administration,  Acute onset since receiving vaccine - low blood count, feeling cold daily, fatigue, feeling terrible, feeling weak, feeling like she is going to pass out.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Peripheral coldness, Presyncope, Red blood cell sedimentation rate
Clinical narrative: Weakness, body pain, hold and cold temperature to extremities - started approx 2 hours after vaccine administration,  Acute onset since receiving vaccine - low blood count, feeling cold daily, fatigue, feeling terrible, feeling weak, feeling like she is going to pass out.
Age: 12.0
Sex: F
Vaccine: HPV9, MNQ, TDAP
Symptoms: Head injury, Loss of consciousness, Seizure, Skin laceration
Clinical narrative: BP 98/60 at time vaccines administered  After vaccines patient and mother stayed in the  room for 3 to 4 minutes, then walked out in hallway towards exit door but patient fell unconscious hit her head against edge of counter wall, had a 10 second seizure and within 30 seconds became alert and responsive, not sleepy or drowsy Pt was taken in wheelchair back to exam room laceration noted on scalp occipital area, gauze given to stop bleed. Pressure applied EMS 911 called and paramedics arrived 7 minutes later, BP 149/90 and taken to ER Pt is better still with staple stitches on scalp Per mom. To follow up here expected 7/23/2021
Age: 52.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Urticaria
Clinical narrative: Adverse event: approximately  one week after receiving the second Moderna dose (02/02/2021) hives were observed mostly on the chest, waist, back and thighs; also experienced occasional welts on stomach and arms. Noticed swelling appear in face, lips, eyes and cheeks. Denied experiencing  trouble breathing and any other symptoms of a severe allergic reaction.  Treatment: Seen by a doctor, was first prescribed "Pepcid," took it for about 1 week and saw the hives improve. After noticing a reappearance of episodes of hives and swelling occur, was given "bentimodine" that helped subdue symptoms. Now is on a prescribed regimen of Montelukast 10mg at night, famotidine 20mg BID, zyrtec BID.   (continue on lower page)
Age: 52.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Adverse event, Eye swelling, Lip swelling, Swelling face, Urticaria
Clinical narrative: Adverse event: approximately  one week after receiving the second Moderna dose (02/02/2021) hives were observed mostly on the chest, waist, back and thighs; also experienced occasional welts on stomach and arms. Noticed swelling appear in face, lips, eyes and cheeks. Denied experiencing  trouble breathing and any other symptoms of a severe allergic reaction.  Treatment: Seen by a doctor, was first prescribed "Pepcid," took it for about 1 week and saw the hives improve. After noticing a reappearance of episodes of hives and swelling occur, was given "bentimodine" that helped subdue symptoms. Now is on a prescribed regimen of Montelukast 10mg at night, famotidine 20mg BID, zyrtec BID.   (continue on lower page)
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Balance disorder, Vestibular function test normal
Clinical narrative: Severe dizziness; Unsteadiness; Slight ringing in ears; This is a spontaneous report from a contactable consumer, the patient. A 69-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: El9263), via an unspecified route of administration in the right arm on 03Feb2021 at 09:00 (at the age of 69-years-old), as single dose for COVID-19 immunisation. Medical history included COVID-19, pernicious anemia and penicillin allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: El3246), via an unspecified route of administration in left arm on 13Jan2021 (at the age of 69-years-old), as a single dose for COVID-19 immunisation. Since the vaccination, patient had not been tested for COVID-19. Prior to vaccination, the patient was diagnosed with COVID-19. Concomitant medication included nortriptyline (MANUFACTURER UNKNOWN), fish oil (MANUFACTURER UNKNOWN), probiotic (unspecified) (MANUFACTURER UNKNOWN), lysine (MANUFACTURER UNKNOWN) and vitamin (unspecified) (MANUFACTURER UNKNOWN); all taken for unknown indication from an unknown date. On 17Feb2021 at 00:00, the patient experienced severe dizziness and unsteadiness, with slight ringing in my ears. This lasted about two weeks and was slowly diminishing. The patient still had a slight off feeling in the head and when the patient turned head still had slight ringing in both the ears. The adverse events resulted in doctor or other healthcare professional office or clinic visit. The patient received treatment for dizziness, unsteadiness and slight ringing in ears, which included videonystagmography test and was given ster. The clinical outcomes of the events dizziness, unsteadiness and slight ringing in ears were resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Balance disorder, Dizziness, Electronystagmogram, Tinnitus
Clinical narrative: Severe dizziness; Unsteadiness; Slight ringing in ears; This is a spontaneous report from a contactable consumer, the patient. A 69-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: El9263), via an unspecified route of administration in the right arm on 03Feb2021 at 09:00 (at the age of 69-years-old), as single dose for COVID-19 immunisation. Medical history included COVID-19, pernicious anemia and penicillin allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: El3246), via an unspecified route of administration in left arm on 13Jan2021 (at the age of 69-years-old), as a single dose for COVID-19 immunisation. Since the vaccination, patient had not been tested for COVID-19. Prior to vaccination, the patient was diagnosed with COVID-19. Concomitant medication included nortriptyline (MANUFACTURER UNKNOWN), fish oil (MANUFACTURER UNKNOWN), probiotic (unspecified) (MANUFACTURER UNKNOWN), lysine (MANUFACTURER UNKNOWN) and vitamin (unspecified) (MANUFACTURER UNKNOWN); all taken for unknown indication from an unknown date. On 17Feb2021 at 00:00, the patient experienced severe dizziness and unsteadiness, with slight ringing in my ears. This lasted about two weeks and was slowly diminishing. The patient still had a slight off feeling in the head and when the patient turned head still had slight ringing in both the ears. The adverse events resulted in doctor or other healthcare professional office or clinic visit. The patient received treatment for dizziness, unsteadiness and slight ringing in ears, which included videonystagmography test and was given ster. The clinical outcomes of the events dizziness, unsteadiness and slight ringing in ears were resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 72.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Asthenia, Feeling abnormal, Guillain-Barre syndrome, Immunoglobulin therapy, Lumbar puncture abnormal
Clinical narrative: paralyzed from feet all way up to face,bottom half is starting to respond but the upper part is not; extreme pain in the back; Guillain-Barre syndrome; This spontaneous case was reported by a consumer and describes the occurrence of GUILLAIN-BARRE SYNDROME (Guillain-Barre syndrome), PARALYSIS (paralyzed from feet all way up to face,bottom half is starting to respond but the upper part is not) and BACK PAIN (extreme pain in the back) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In January 2021, the patient experienced GUILLAIN-BARRE SYNDROME (Guillain-Barre syndrome) (seriousness criteria hospitalization prolonged and medically significant), PARALYSIS (paralyzed from feet all way up to face,bottom half is starting to respond but the upper part is not) (seriousness criteria hospitalization prolonged and medically significant) and BACK PAIN (extreme pain in the back) (seriousness criterion hospitalization prolonged). The patient was hospitalized for 10 days due to GUILLAIN-BARRE SYNDROME. At the time of the report, GUILLAIN-BARRE SYNDROME (Guillain-Barre syndrome), PARALYSIS (paralyzed from feet all way up to face,bottom half is starting to respond but the upper part is not) and BACK PAIN (extreme pain in the back) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not reported. Patient developed Guillain-Barre syndrome and was paralyzed from feet all the way up to her face and had extreme back pain. Following the hospitalization, the patient began rehabilitation which continues. The patient was also prescribed unspecified treatment medication to help with symptoms beginning on an unspecified date.   Company Comment: Very limited information regarding these events has been provided at this time. Further information has been requested.; Sender's Comments: Very limited information regarding these events has been provided at this time. Further information has been requested.
Age: 72.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Back pain, Guillain-Barre syndrome, Paralysis
Clinical narrative: paralyzed from feet all way up to face,bottom half is starting to respond but the upper part is not; extreme pain in the back; Guillain-Barre syndrome; This spontaneous case was reported by a consumer and describes the occurrence of GUILLAIN-BARRE SYNDROME (Guillain-Barre syndrome), PARALYSIS (paralyzed from feet all way up to face,bottom half is starting to respond but the upper part is not) and BACK PAIN (extreme pain in the back) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In January 2021, the patient experienced GUILLAIN-BARRE SYNDROME (Guillain-Barre syndrome) (seriousness criteria hospitalization prolonged and medically significant), PARALYSIS (paralyzed from feet all way up to face,bottom half is starting to respond but the upper part is not) (seriousness criteria hospitalization prolonged and medically significant) and BACK PAIN (extreme pain in the back) (seriousness criterion hospitalization prolonged). The patient was hospitalized for 10 days due to GUILLAIN-BARRE SYNDROME. At the time of the report, GUILLAIN-BARRE SYNDROME (Guillain-Barre syndrome), PARALYSIS (paralyzed from feet all way up to face,bottom half is starting to respond but the upper part is not) and BACK PAIN (extreme pain in the back) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not reported. Patient developed Guillain-Barre syndrome and was paralyzed from feet all the way up to her face and had extreme back pain. Following the hospitalization, the patient began rehabilitation which continues. The patient was also prescribed unspecified treatment medication to help with symptoms beginning on an unspecified date.   Company Comment: Very limited information regarding these events has been provided at this time. Further information has been requested.; Sender's Comments: Very limited information regarding these events has been provided at this time. Further information has been requested.
Age: 72.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Guillain-Barre syndrome, Lumbar puncture
Clinical narrative: paralyzed from feet all way up to face,bottom half is starting to respond but the upper part is not; extreme pain in the back; Guillain-Barre syndrome; This spontaneous case was reported by a consumer and describes the occurrence of GUILLAIN-BARRE SYNDROME (Guillain-Barre syndrome), PARALYSIS (paralyzed from feet all way up to face,bottom half is starting to respond but the upper part is not) and BACK PAIN (extreme pain in the back) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In January 2021, the patient experienced GUILLAIN-BARRE SYNDROME (Guillain-Barre syndrome) (seriousness criteria hospitalization prolonged and medically significant), PARALYSIS (paralyzed from feet all way up to face,bottom half is starting to respond but the upper part is not) (seriousness criteria hospitalization prolonged and medically significant) and BACK PAIN (extreme pain in the back) (seriousness criterion hospitalization prolonged). The patient was hospitalized for 10 days due to GUILLAIN-BARRE SYNDROME. At the time of the report, GUILLAIN-BARRE SYNDROME (Guillain-Barre syndrome), PARALYSIS (paralyzed from feet all way up to face,bottom half is starting to respond but the upper part is not) and BACK PAIN (extreme pain in the back) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not reported. Patient developed Guillain-Barre syndrome and was paralyzed from feet all the way up to her face and had extreme back pain. Following the hospitalization, the patient began rehabilitation which continues. The patient was also prescribed unspecified treatment medication to help with symptoms beginning on an unspecified date.   Company Comment: Very limited information regarding these events has been provided at this time. Further information has been requested.; Sender's Comments: Very limited information regarding these events has been provided at this time. Further information has been requested.
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dysphagia, Eye swelling, Mouth swelling, Oral mucosal eruption, Pharyngeal swelling
Clinical narrative: tongue and lips began swelling; tongue and lips began swelling; difficulty breathing; This is a spontaneous report from a contactable consumer (patient). A 59-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot Number: ER3730), via an unspecified route of administration in the left arm, on 31Mar2021 at 12:00 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. Medical history included hemachromatosis and allergies to sulfa drugs. The patient was not pregnant at the time of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included unspecified medications taken within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient experienced tongue and lips began swelling and difficulty breathing on 31Mar2021 at 12:00. The clinical course was reported as follows: Within 5 minutes (as reported) of getting the dose, the patient's tongue and lips began swelling and she had difficulty breathing. Two doses of diphenhydramine hydrochloride (BENADRYL), at two 25 mg tablets, were administered, but she was still experiencing less severe symptoms 48 hours later. Therapeutic measures were taken as a result of tongue and lips began swelling and difficulty breathing as aforementioned. The clinical outcome of tongue and lips began swelling and difficulty breathing recovered with sequelae (reported as: with lasting effects) on an unspecified date. It was also reported that since the vaccination, the patient had not been tested for COVID-19.
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Swelling face, Swollen tongue, Throat tightness, Vaccination complication
Clinical narrative: tongue and lips began swelling; tongue and lips began swelling; difficulty breathing; This is a spontaneous report from a contactable consumer (patient). A 59-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot Number: ER3730), via an unspecified route of administration in the left arm, on 31Mar2021 at 12:00 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. Medical history included hemachromatosis and allergies to sulfa drugs. The patient was not pregnant at the time of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included unspecified medications taken within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient experienced tongue and lips began swelling and difficulty breathing on 31Mar2021 at 12:00. The clinical course was reported as follows: Within 5 minutes (as reported) of getting the dose, the patient's tongue and lips began swelling and she had difficulty breathing. Two doses of diphenhydramine hydrochloride (BENADRYL), at two 25 mg tablets, were administered, but she was still experiencing less severe symptoms 48 hours later. Therapeutic measures were taken as a result of tongue and lips began swelling and difficulty breathing as aforementioned. The clinical outcome of tongue and lips began swelling and difficulty breathing recovered with sequelae (reported as: with lasting effects) on an unspecified date. It was also reported that since the vaccination, the patient had not been tested for COVID-19.
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea, Lip swelling, Swollen tongue
Clinical narrative: tongue and lips began swelling; tongue and lips began swelling; difficulty breathing; This is a spontaneous report from a contactable consumer (patient). A 59-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot Number: ER3730), via an unspecified route of administration in the left arm, on 31Mar2021 at 12:00 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. Medical history included hemachromatosis and allergies to sulfa drugs. The patient was not pregnant at the time of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included unspecified medications taken within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient experienced tongue and lips began swelling and difficulty breathing on 31Mar2021 at 12:00. The clinical course was reported as follows: Within 5 minutes (as reported) of getting the dose, the patient's tongue and lips began swelling and she had difficulty breathing. Two doses of diphenhydramine hydrochloride (BENADRYL), at two 25 mg tablets, were administered, but she was still experiencing less severe symptoms 48 hours later. Therapeutic measures were taken as a result of tongue and lips began swelling and difficulty breathing as aforementioned. The clinical outcome of tongue and lips began swelling and difficulty breathing recovered with sequelae (reported as: with lasting effects) on an unspecified date. It was also reported that since the vaccination, the patient had not been tested for COVID-19.
Age: 50.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Nausea
Clinical narrative: Extreme dizziness; Nausea; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733), via an unspecified route of administration in the left arm on 29Mar2021(at the age of 50-years-old), as a single dose for COVID-19 immunisation. Medical history included high blood pressure. The patient did not have any allergies to medications, food, or other products. The patient received medications for blood pressure within 2 weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206), via an unspecified route of administration in the left arm on 07Mar2021 at 17:30 (at the age of 50-years-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the vaccination. On 30Mar2021 at 01:00, the patient experienced dizziness and nausea. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. The clinical outcome of the events dizziness and nausea were not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.